Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Millennium Gloucester Hotel London Kensington

Sep 24, 2014 8:00 AM - Sep 25, 2014 5:30 PM

4-18 Harrington Gardens, London, SW7 4LH, United Kingdom

Clinical Trials Workshop II - Translating the New Transparency Requirements into Practice

WED Session 4: INDUSTRY COMMITMENT – FROM DATA SHARING POLICY TO IMPLEMENTATION

Session Chair(s)

Hanns-Georg  Leimer, PhD

Hanns-Georg Leimer, PhD

Global Head Central Solutions and Services Medicine (CSSM) in Global Biostatisti

Boehringer Ingelheim Pharma GmbH&CO KG, Germany

Speaker(s)

Robert  Frost

How does the new policy translate for the industry? A company approach

Robert Frost

GlaxoSmithKline, United Kingdom

Policy Director

Victoria  Kitcatt, LLM

Commercially Confidential Information – Where to draw the line?

Victoria Kitcatt, LLM

Pfizer Limited, United Kingdom

Vice President and Assistant General Counsel, European Regulatory Law

Rebecca  Sudlow, MS

How may data transparency contribute to improving the development of medicines?

Rebecca Sudlow, MS

Roche, United Kingdom

Global Lead Patient Level Data Sharing

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.